EVFM
Evofem Biosciences, Inc. Common Stock
EVFM
EVFM
Delisted
EVFM was delisted on the 10th of August, 2022.
68 hedge funds and large institutions have $9.84M invested in Evofem Biosciences, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 14 increasing their positions, 17 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
18% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 17
Holders
68
Holding in Top 10
–
Calls
$714K
Puts
$143K
Top Buyers
| 1 | +$928K | |
| 2 | +$95.5K | |
| 3 | +$54.1K | |
| 4 |
Morgan Stanley
New York
|
+$30.8K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$17K |
Top Sellers
| 1 | -$1.01M | |
| 2 | -$601K | |
| 3 | -$347K | |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$274K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$160K |